Intrahepatic Cholangiocarcinoma  >>  capecitabine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
capecitabine / Generic mfg.
NCT00084942: Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder

Completed
2
US
capecitabine, gemcitabine hydrochloride
Roswell Park Cancer Institute
Extrahepatic Bile Duct Cancer, Gallbladder Cancer
05/04
11/06
SAKK 44/02, NCT00073905: Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Completed
2
44
Europe
capecitabine plus gemcitabine
Swiss Group for Clinical Cancer Research
Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer, Pain
06/06
01/09
NCT00033540: S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

Completed
2
57
US
capecitabine, Xeloda (NSC-712807), gemcitabine hydrochloride, Gemzar (NSC-613327)
Southwest Oncology Group, National Cancer Institute (NCI)
Extrahepatic Bile Duct Cancer, Gallbladder Cancer
04/08
07/11
NCT01534637: Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Completed
2
22
US
aprepitant, Emend, L-754030, MK-0869, ONO-7436, gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar, capecitabine, CAPE, Ro 09-1978/000, Xeloda, fluorouracil, 5-fluorouracil, 5-Fluracil, 5-FU, radiation therapy, irradiation, radiotherapy, therapy, radiation, questionnaire administration, quality-of-life assessment, quality of life assessment, nausea and vomiting therapy, antiemetic support, management of nausea and vomiting, nausea and vomiting management, therapy, nausea and vomiting, vomiting and nausea management, management of therapy complications, complications of therapy, management of
Wake Forest University Health Sciences, National Cancer Institute (NCI), Merck Sharp & Dohme LLC
Extrahepatic Bile Duct Cancer, Nausea, Vomiting, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
12/09
08/12
NCT01151761: Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation

Terminated
2
2
US
Stereotactic Body Radiotherapy, External photon radiation, Gemcitabine, Gemzar, Cisplatin, Platinol, Platinol-AQ, Carboplatin, Paraplatin, Paraplatin-AQ, Capecitabine, Xeloda, 5FU, Fluorouracil, Adrucil, Carac, Efudix, Efudex, Fluoroplex, Liver transplantation
Stanford University
Cholangiocarcinoma, Hepatobiliary Neoplasm, Liver Cancer, Bile Duct Cancer, Cancer of Gallbladder
04/12
07/12
S0809, NCT00789958: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

Completed
2
105
US
capecitabine, Xeloda, NSC-712807, gemcitabine hydrochloride, Gemzar, NSC-619927, 3-dimensional conformal radiation therapy, 3D radiotherapy, intensity-modulated radiation therapy, IMRT
Southwest Oncology Group, National Cancer Institute (NCI)
Extrahepatic Bile Duct Cancer, Gallbladder Cancer
12/14
12/17
SWOG-S1310, NCT02042443: Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Completed
2
53
US
Capecitabine, Ro 09-1978/000, Xeloda, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Laboratory Biomarker Analysis, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Trametinib, GSK1120212, JTP-74057, MEK Inhibitor GSK1120212, Mekinist
National Cancer Institute (NCI)
Adult Cholangiocarcinoma, Advanced Adult Hepatocellular Carcinoma, BCLC Stage C Adult Hepatocellular Carcinoma, BCLC Stage D Adult Hepatocellular Carcinoma, Hilar Cholangiocarcinoma, Localized Non-Resectable Adult Liver Carcinoma, Recurrent Adult Liver Carcinoma, Recurrent Childhood Liver Cancer, Recurrent Extrahepatic Bile Duct Carcinoma, Recurrent Gallbladder Carcinoma, Stage II Gallbladder Cancer, Stage III Childhood Hepatocellular Carcinoma, Stage IIIA Gallbladder Cancer, Stage IIIB Gallbladder Cancer, Stage IV Childhood Hepatocellular Carcinoma, Stage IV Distal Bile Duct Cancer, Stage IVA Gallbladder Cancer, Stage IVB Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Carcinoma
01/17
04/17
NCT00021047: Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Completed
1/2
US
capecitabine, carboplatin, epirubicin hydrochloride
National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI)
Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Unspecified Adult Solid Tumor, Protocol Specific
 
06/04

Download Options